Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0010 USD
Change Today -0.0003 / -23.08%
Volume 191.4K
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

bionovo inc (BNVIQ) Snapshot

Open
$0.0010
Previous Close
$0.0013
Day High
$0.0010
Day Low
$0.0010
52 Week High
04/3/14 - $0.0069
52 Week Low
12/31/14 - $0.0006
Market Cap
80.3K
Average Volume 10 Days
156.1K
EPS TTM
$-0.28
Shares Outstanding
80.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIONOVO INC (BNVIQ)

Related News

No related news articles were found.

bionovo inc (BNVIQ) Related Businessweek News

No Related Businessweek News Found

bionovo inc (BNVIQ) Details

Bionovo, Inc., a pharmaceutical company, is focused on the discovery and development of drugs for the treatment of unmet medical needs in women’s health and cancer in the United States. The company’s drug development process utilizes botanical sources used in traditional Chinese medicine to produce biologically active compounds. Its lead drug candidate, Menerba, a selective estrogen receptor beta agonist, is a proprietary oral formulation of 18 botanically derived active pharmaceutical ingredients designed to reduce the frequency and severity of menopausal hot flashes. This drug candidate is in Phase III clinical trial for the treatment of hot flashes. The company is also developing Bezielle, an oral anti-cancer agent, which is in two separate Phase I clinical trials for treating advanced breast cancer and pancreatic cancer; and Seala for the treatment of postmenopausal vaginal atrophy and dryness. Bionovo, Inc. was founded in 2002 and is headquartered in Emeryville, California. On October 26, 2012, Bionovo, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Northern District of California.

5 Employees
Last Reported Date: 03/30/12
Founded in 2002

bionovo inc (BNVIQ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BNVIQ:US $0.00 USD -0.0003

BNVIQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BNVIQ.
View Industry Companies
 

Industry Analysis

BNVIQ

Industry Average

Valuation BNVIQ Industry Range
No financial data is available for BNVIQ.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIONOVO INC, please visit www.bionovo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.